I don’t normally pay much attention to the world of high fashion, but the controversy sparked by last month’s Paris fashion ...

In the ever-changing healthcare landscape, it is crucial to develop sustainable long-term strategies that look beyond ...

SeroLean is a new weight loss system that addresses the most frequent causes ... ensuring they could provide comprehensive ...

An online store has jumped on the Ozempic craze by releasing a “sexy” semaglutide injection costume just in time for ...

It's been a very difficult year for Walgreens Boots Alliance (NASDAQ: WBA), which has seen its stock lose two-thirds of its ...

Novo Nordisk CEO Lars Fruergaard Jorgensen has called attention to the complexities of the U.S. healthcare system while ...

Vice President Kamala Harris, the Democratic presidential nominee, released a letter from her physician on Saturday, ...

A program to accelerate drug trials often provides the market with new drugs that are only marginally more effective, but ...

A dietitian shares the science-backed weight loss supplements that support weight loss when paired with a balanced diet and active lifestyle.

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

New drugs from public and private companies are expected to saturate the obesity drug market. Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market, but biopharmaceutical ...

L.A. is particularly susceptible to “miracle” cures. And there are some troubling aspects of the Ozempic gold rush that don’t ...